allergen avoidance, allergen immunotherapy, allergic rhinoconjunctivits, clinical outcomes, clinical trials, pharmacotherapy
dx.doi.org/10.1097/ACI.0000000000000164, hdl.handle.net/1765/88981
Current Opinion in Allergy and Clinical Immunology
Erasmus MC: University Medical Center Rotterdam

Pfaar, O, Klimek, L, & Gerth van Wijk, R. (2015). Clinically relevant outcome measures for new pharmacotherapy, allergen avoidance and immunotherapy trials in allergic rhinoconjunctivitis. Current Opinion in Allergy and Clinical Immunology (Vol. 15, pp. 197–203). doi:10.1097/ACI.0000000000000164